by Plus Therapeutics | Oct 25, 2024 | GBM
Join us at the upcoming @glioblastomaresearch Glioblastoma Patient Summit as Plus Therapeutics takes the stage! The summit will be held November 1-3 in Miami, FL, and include panel talks from neurosurgeons and neuro-oncologists as well as an opportunity to connect...
by Plus Therapeutics | Oct 8, 2024 | GBM
#ICYMI Plus Therapeutics exhibited at the #CNS2024 Annual Meeting and Dr. John Floyd presented a ReSPECT-GBM clinical trial update Key Highlights:...
by Plus Therapeutics | Oct 1, 2024 | GBM
Plus Therapeutics presented an update on the ongoing ReSPECT-GBM Phase 1/2 clinical trial, evaluating Rhenium (186Re) Obisbemeda for the treatment of recurrent glioblastoma at the 2024 Congress of Neurological Surgeons (CNS) Annual Meeting yesterday. Key...
by Plus Therapeutics | Sep 12, 2024 | GBM
Join us at the @HeadfortheCure Caregiver Conversations support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. respect-trials.com/gbm Join Brains for the Cure the 2nd Thursday of each month on Zoom at 7...
by Plus Therapeutics | Jul 19, 2024 | GBM
“A lot of the battles that [GBM] picks are people that are truly going to fight back and give hope to the next patient…” ✊ Watch the full interview with Olympic Athlete & Brain Cancer Champion Scott Hamilton: https://bit.ly/4bKiufQ Social Media:...
by Plus Therapeutics | Jun 12, 2024 | GBM
📣 ReSPECT-GBM Clinical Trial is now a @the_abta Featured Clinical Study Check it out here: https://bit.ly/45iB7WE The American Brain Tumor Association’s (ABTA) Featured Clinical Trial Program is part of their ongoing efforts to educate and support patients with brain...
Recent Comments